| Dr Zeeshan Ahmad, M D | |
|
550 Osborne Rd Ne, Fridley, MN 55432-2718 | |
| (763) 236-3518 | |
| Not Available |
| Full Name | Dr Zeeshan Ahmad |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 23 Years |
| Location | 550 Osborne Rd Ne, Fridley, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881844058 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 56468 (Minnesota) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 27605 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| United Hospital Center | Bridgeport, WV | Hospital |
| St Joseph's Hospital | Buckhannon, WV | Hospital |
| West Virginia University Hospitals | Morgantown, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Joseph's Hospital Of Buckhannon Inc | 6709828163 | 42 |
| United Hospital Center Inc | 8123936010 | 209 |
News Archive
The global CT market is expected to grow 5.5 percent to $5.1 billion in 2018, according to a new Kalorama Information report. The combination of product enhancements and the need to cut radiation dose levels is fueling the market. A new federal standard passed into law last year, NEMA Standard XR-29, defining low dose standards and punishing providers not in compliance will help growth, according to the market research publisher.
Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to review data for Avastin's use in metastatic HER2-negative breast cancer. In light of today's news that the FDA has recommended removing Avastin's approval to treat breast cancer, Breastcancer.org is making public Dr. Weiss' ODAC letter in its entirety.
Assurances from the Australian Medical Association (AMA) that cancer patients at the Royal Adelaide Hospital are at a minimal risk from an inadvertent 5 per cent reduction in their prescribed radiation dosage between 2004 to 2006, may reassure some but many former patients will still be worried.
An incredible 94% of smokers surveyed said they recognised at least one element of the 'Give Up Before You Clog Up' campaign, with the 'dripping fat cigarette' TV advert sticking in the memories of 90% of those surveyed. The survey was conducted by leading research agency, Hall and Partners, who say the statistics beat any other advertising campaign they have worked on.
› Verified 4 days ago
| Entity Name | United Hospital Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760965586 PECOS PAC ID: 8123936010 Enrollment ID: O20031212000802 |
News Archive
The global CT market is expected to grow 5.5 percent to $5.1 billion in 2018, according to a new Kalorama Information report. The combination of product enhancements and the need to cut radiation dose levels is fueling the market. A new federal standard passed into law last year, NEMA Standard XR-29, defining low dose standards and punishing providers not in compliance will help growth, according to the market research publisher.
Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to review data for Avastin's use in metastatic HER2-negative breast cancer. In light of today's news that the FDA has recommended removing Avastin's approval to treat breast cancer, Breastcancer.org is making public Dr. Weiss' ODAC letter in its entirety.
Assurances from the Australian Medical Association (AMA) that cancer patients at the Royal Adelaide Hospital are at a minimal risk from an inadvertent 5 per cent reduction in their prescribed radiation dosage between 2004 to 2006, may reassure some but many former patients will still be worried.
An incredible 94% of smokers surveyed said they recognised at least one element of the 'Give Up Before You Clog Up' campaign, with the 'dripping fat cigarette' TV advert sticking in the memories of 90% of those surveyed. The survey was conducted by leading research agency, Hall and Partners, who say the statistics beat any other advertising campaign they have worked on.
› Verified 4 days ago
| Entity Name | St Joseph's Hospital Of Buckhannon Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124005061 PECOS PAC ID: 6709828163 Enrollment ID: O20050525000839 |
News Archive
The global CT market is expected to grow 5.5 percent to $5.1 billion in 2018, according to a new Kalorama Information report. The combination of product enhancements and the need to cut radiation dose levels is fueling the market. A new federal standard passed into law last year, NEMA Standard XR-29, defining low dose standards and punishing providers not in compliance will help growth, according to the market research publisher.
Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to review data for Avastin's use in metastatic HER2-negative breast cancer. In light of today's news that the FDA has recommended removing Avastin's approval to treat breast cancer, Breastcancer.org is making public Dr. Weiss' ODAC letter in its entirety.
Assurances from the Australian Medical Association (AMA) that cancer patients at the Royal Adelaide Hospital are at a minimal risk from an inadvertent 5 per cent reduction in their prescribed radiation dosage between 2004 to 2006, may reassure some but many former patients will still be worried.
An incredible 94% of smokers surveyed said they recognised at least one element of the 'Give Up Before You Clog Up' campaign, with the 'dripping fat cigarette' TV advert sticking in the memories of 90% of those surveyed. The survey was conducted by leading research agency, Hall and Partners, who say the statistics beat any other advertising campaign they have worked on.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Zeeshan Ahmad, M D 2673 Davisson Run Rd Ste 303, Clarksburg, WV 26301-7640 Ph: (800) 541-4009 | Dr Zeeshan Ahmad, M D 550 Osborne Rd Ne, Fridley, MN 55432-2718 Ph: (763) 236-3518 |
News Archive
The global CT market is expected to grow 5.5 percent to $5.1 billion in 2018, according to a new Kalorama Information report. The combination of product enhancements and the need to cut radiation dose levels is fueling the market. A new federal standard passed into law last year, NEMA Standard XR-29, defining low dose standards and punishing providers not in compliance will help growth, according to the market research publisher.
Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to review data for Avastin's use in metastatic HER2-negative breast cancer. In light of today's news that the FDA has recommended removing Avastin's approval to treat breast cancer, Breastcancer.org is making public Dr. Weiss' ODAC letter in its entirety.
Assurances from the Australian Medical Association (AMA) that cancer patients at the Royal Adelaide Hospital are at a minimal risk from an inadvertent 5 per cent reduction in their prescribed radiation dosage between 2004 to 2006, may reassure some but many former patients will still be worried.
An incredible 94% of smokers surveyed said they recognised at least one element of the 'Give Up Before You Clog Up' campaign, with the 'dripping fat cigarette' TV advert sticking in the memories of 90% of those surveyed. The survey was conducted by leading research agency, Hall and Partners, who say the statistics beat any other advertising campaign they have worked on.
› Verified 4 days ago
Dr. Theodore A Longinow, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 550 Osborne Rd Ne, Fridley, MN 55432 Phone: 763-236-5000 | |
Dr. Reuben Nicholas Lubka, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 6341 University Ave Ne, Fridley, MN 55432 Phone: 763-572-5710 Fax: 763-586-5888 | |
Eleanor Mariano Beltran, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 7675 Madison St Ne, Fridley, MN 55432 Phone: 763-785-4500 Fax: 763-785-3314 | |
Maria Dana Tudor, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 480 Osborne Rd Ne, Suite 100, Fridley, MN 55432 Phone: 763-785-4500 Fax: 763-785-3329 | |
Joudat I. Yazigi, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 550 Osborne Rd Ne, Fridley, MN 55432 Phone: 763-236-3518 | |
Uzma Ali, MBBS Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 480 Osborne Rd Ne, Suite 220, Fridley, MN 55432 Phone: 763-786-1620 Fax: 763-780-3099 | |
Dr. Dorothy L Uhlman, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 500 Osborne Road, Suite 215, Fridley, MN 55432 Phone: 763-786-1620 Fax: 763-780-2624 |